NK cell natural cytotoxicity and IFN-γ production are not always coordinately regulated: Engagement of DX9 KIR+ NK cells by HLA-B7 variants and target cells

Journal of Immunology

Volumn 160, Issue 4, 1998, Pages 1573-1580

  Kurago, Zoya B ^a,b   Lutz, Charles T ^a,b   Smith, Kelly D ^a,b,c   Colonna, Marco ^d  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^d BASEL INSTITUTE FOR IMMUNOLOGY   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; HLA B7 ANTIGEN;

ANTIGEN EXPRESSION; ANTIGEN RECOGNITION; ARTICLE; CELL STRAIN K 562; CONTROLLED STUDY; CYTOTOXICITY; HLA SYSTEM; HUMAN; HUMAN CELL; NATURAL KILLER CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TARGET CELL;

ALLELES; ANTIBODIES, MONOCLONAL; CELL LINE; CLONE CELLS; CYTOTOXICITY TESTS, IMMUNOLOGIC; CYTOTOXICITY, IMMUNOLOGIC; EPITOPES; HLA-B ANTIGENS; HLA-B7 ANTIGEN; HUMANS; IMMUNITY, NATURAL; INTERFERON TYPE II; KILLER CELLS, NATURAL; RECEPTORS, IMMUNOLOGIC; VARIATION (GENETICS);

EID: 0032519671     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Trinchieri, G. 1989. Biology of natural killer cells. Adv. Immunol. 47:187.
2. Lanier, L. L., B. Corliss, and J. H. Phillips. 1997. Arousal and inhibition of human NK cells. Immunol. Rev. 155:145.
3. Boehm, U., T. Klamp, M. Groot, and J. C. Howard. 1997. Cellular responses to interferon-γ. Annu. Rev. Immunol. 15:749.
4. Leibson, P. J. 1997. Signal transduction during natural killer cell activation: inside the mind of a killer. Immunity 6:655.
5. Bonnema, J. D., and P. J. Leibson. 1996. Signal transduction during NK cell activation. Chem. Immunol. 64:28.
6. Wagtmann, N., S. Rajagopalan, C. C. Winter, M. Peruzzi, and E. O. Long. 1995. Killer cell inhibitory receptors specific for HLA-C and HLA-B identified by direct binding and by functional transfer. Immunity 3:301.
7. Döhring, C., D. Scheidegger, J. Samaridis, M. Cella, and M. Colonna. 1996. A human killer inhibitory receptor specific for HLA-A. J. Immunol. 156:3098.
8. Fan, Q. R., D. N. Garboczi, C. C. Winter, N. Wagtmann, E. O. Long, and D. C. Wiley. 1996. Direct binding of a soluble natural killer cell inhibitory receptor to a soluble human leukocyte antigen-Cw4 class I major histocompatibility complex molecule. Proc. Natl. Acad. Sci. USA 93:7178.
9. Binstadt, B. A., K. M. Brumbaugh, C. J. Dick, A. M. Scharenberg, B. L. Williams, M. Colonna, L. L. Lanier, J.-P. Kinet, R. T. Abraham, and P. J. Leibson. 1996. Sequential involvement of Lck and SHP-1 with MHC-recognizing receptors on NK cells inhibits FcR-initiated tyrosine kinase activation. Immunity 5:629.
10. Burshtyn, D. N., A. M. Scharenberg, N. Wagtmann, S. Rajagopalan, K. Berrada, T. Yi, J.-P. Kinet, and E. O. Long. 1996. Recruitment of tyrosine phosphatase HCP by the killer cell inhibitory receptor. Immunity 4:77.
11. Fry, A. M., L. L. Lanier, and A. Weiss. 1996. Phosphotyrosines in the killer cell inhibitory receptor motif of NKB1 are required for negative signaling and for association with protein tyrosine phosphatase 1C. J. Exp. Med. 184:295.
12. Olcese, L., P. Lang, F. Vély, A. Cambiaggi, D. Marguet, M. Bléry, K. L. Hippen, R. Biassoni, A. Moretta, L. Moretta, J. C. Cambier, and E. Vivier. 1996. Human and mouse killer-cell inhibitory receptors recruit PTP1C and PTP1D protein tyrosine phosphatases. J. Immunol. 156:4531.
13. Colonna, M., E. G. Brooks, M. Falco, G. B. Ferrara, and J. L. Strominger. 1993. Generation of allospecific natural killer cells by stimulation across a polymorphism of HLA-C. Science 260:1121.
14. Biassoni, R., M. Falco, A. Cambiaggi, P. Costa, S. Verdiani, D. Pende, R. Conte, C. Di Donato, P. Parham, and L. Moretta. 1995. Amino acid substitutions can influence the natural killer (NK)-mediated recognition of HLA-C molecules: role of serine-77 and lysine-80 in the target cell protection from lysis mediated by "group 2" or "group 1" NK clones. J. Exp. Med. 182:605.
15. Mandelboim, O., H. T. Reyburn, M. Valés-Gómez, L. Pazmany, M. Colonna, G. Borsellino, and J. L. Strominger. 1996. Protection from lysis by natural killer cells of group 1 and 2 specificity is mediated by residue 80 in human histocompatibility leukocyte antigen C alleles and also occurs with empty major histocompatibility complex molecules. J. Exp. Med. 184:913.
16. Litwin, V., J. Gumperz, P. Parham, J. H. Phillips, and L. L. Lanier. 1994. NKB1: an NK cell receptor involved in the recognition of polymorphic HLA-B molecules. J. Exp. Med. 180:537.
17. Gumperz, J. E., V. Litwin, J. H. Phillips, L. L. Lanier, and P. Parham. 1995. The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor. J. Exp. Med. 181:1133.
18. Wan, A. M., P. Ennis, P. Parham, and N. Holmes. 1986. The primary structure of HLA-A32 suggests a region involved in formation of the Bw4/Bw6 epitopes. J. Immunol. 137:3671.
19. Arnaiz-Villena, A., M. Belvedere, F. Decary, M. Fotino, E. Heise, V. Hogan, M. Martinetti, C. Muller, P. Richiardi, J. L. Vicario, M. Barbanti, J. Bruyere, C. Caruso, C. Conighi, K. Gelsthorpe, M. Hammond, C. Lopez-Larrea, H. Mervart, D. Peruccio, J. R. Regueiro, and I. Schreuder. 1989. Antigen Society #15 report (Bw4 and Bw6). In Immunobiology of HLA. B. Dupont, ed. Springer-Verlag, New York, p. 214-217.
20. Gumperz, J. E., L. D. Barber, N. M. Valiante, L. Percival, J. H. Phillips, L. L. Lanier, and P. Parham. 1997. Conserved and variable residues within the Bw4 motif of HLA-B make separable contributions to recognition by the NKB1 killer cell-Inhibitory receptor. J. Immunol. 158:5237.
21. Wagtmann, N., R. Biassoni, C. Cantoni, S. Verdiani, M. S. Malnati, M. Vitale, C. Bottino, L. Moretta, A. Moretta, and E. O. Long. 1995. Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra-and intracellular domains. Immunity 2:439.
22. Cella, M., A. Longo, G. B. Ferrara, J. L. Strominger, and M. Colonna. 1994. NK3-specific natural killer cells are selectively inhibited by Bw4-positive HLA alleles with isoleucine 80. J. Exp. Med. 180:1235.
23. Luque, I., R. Solana, D. M. Galiani, R. González, F. García, J. A. López de Castro, and J. Peńa. 1996. Threonine 80 on HLA-B27 confers protection against lysis by a group of natural killer clones. Eur. J. Immunol. 26:1974.
24. Farrar, W. L., M. C. Birchenall-Sparks, and H. B. Young. 1986. Interleukin 2 induction of interferon-γ mRNA synthesis. J. Immunol. 137:3836.
25. Anegón, I., M. C. Cuturi, G. Trinchieri, and B. Perussia. 1988. Interaction of Fc receptor (CD16) ligands induces transcription of interleukin 2 receptor (CD25) and lymphokine genes and expression of their products in human natural killer cells. J. Exp. Med. 167:452.
26. Farrar, M. A., and R. D. Schreiber. 1993. The molecular cell biology of interferon-γ and its receptor. Annu. Rev. Immunol. 11:571.
27. Bellone, G., N. M. Valiante, O. Viale, E. Ciccone, L. Moretta, and G. Trinchieri. 1993. Regulation of hematopoiesis in vitro by alloreactive natural killer cell clones. J. Exp. Med. 177:1117.
28. D'Andrea, A., C. Chang, J. H. Phillips, and L. L. Lanier. 1996. Regulation of T cell lymphokine production by killer cell inhibitory receptor recognition of self HLA class I alleles. J. Exp. Med. 184:789.
29. Orange, J., and C. A. Biron. 1996. Characterization of early IL-12, IFN-αγ, and TNF effects on antiviral state and NK cell responses during murine cytomegalovirus infection. J. Immunol. 156:4746.
30. Orange, J. S., and C. A. Biron. 1996. An absolute and restricted requirement for IL-12 in natural killer cell IFN-γ production and antiviral defense: studies of natural killer and T cell responses in contrasting viral infections. J. Immunol. 156:1138.
31. Lutz, C. T., K. D. Smith, N. S. Greazel, B. E. Mace, D. A. Jensen, J. A. McCutcheon, and N. E. Goeken. 1994. Bw4-reactive and Bw6-reactive antibodies recognize multiple distinct HLA structures that partially overlap in the α-1 helix. J. Immunol. 153:4099.
32. Kurago, Z. B., K. D. Smith, and C. T. Lutz. 1995. NK cell recognition of MHC class I: NK cells are sensitive to peptide-binding groove and surface α-helical mutations that affect T cells. J. Immunol. 154:2631.
33. Klinman, D. M., and T. B. Nutman. 1994. ELISPOT assay to detect cytokine-secreting murine and human cells. In Current Protocols in Immunology. J. E. Coligan, A. M. Kruisbeek, D. H. Margulies, E. M. Shevach, and W. Strober, eds. John Wiley & Sons, New York, p. 6.19.1.-6.19.8.
34. Smith, K. D., E. Huczko, V. H. Engelhard, Y.-Y. Li, and C. T. Lutz. 1997. Alloreactive cytotoxic T lymphocytes focus on specific major histocompatibility complex-bound peptides. Transplantation 64:351.
35. Smith, K. D., and C. T. Lutz. 1997. Alloreactive T cell recognition of MHC class I molecules: the T cell receptor interacts with limited regions of the MHC class I long α-helices. J. Immunol. 158:2805.
36. Mandelboim, O., H. T. Reyburn, E. G. Sheu, M. Valés-Gómez, D. M. Davis, L. Pazmany, and J. L. Strominger. 1997. The binding site of NK receptors on HLA-C molecules. Immunity 6:341.
37. Pérez-Villar, J. J., I. Melero, A. Rodríguez, M. Carretero, J. Aramburu, S. Sivori, A. M. Orengo, A. Moretta, and M. López-Botet. 1995. Functional ambivalence of the Kp43 (CD94) NK cell-associated surface antigen. J. Immunol. 154:5779.
38. Phillips, J. H., C. Chang, J. Mattson, J. E. Gumperz, P. Parham, and L. L. Lanier. 1996. CD94 and a novel associated protein (94AP) form a NK cell receptor involved in the recognition of HLA-A, HLA-B, and HLA-C allotypes. Immunity 5:163.
39. Houchins, J. P., L. L. Lanier, E. C. Niemi, J. H. Phillips, and J. C. Ryan. 1997. Natural killer cell cytolytic activity is inhibited by NKG2-A and activated by NKG2-C. J. Immunol. 158:3603.
40. Madden, D. R., J. C. Gorga, J. L. Strominger, and D. C. Wiley. 1992. The three-dimensional structure of HLA-B27 at 2.1 Å resolution suggests a general mechanism for tight peptide binding to MHC. Cell 70:1035.
41. Rammensee, H.-G., T. Friede, and S. Stevanovic. 1995. MHC ligands and peptide motifs: first listing. Immunogenetics 41:178.
42. Correa, I., and D. H. Raulet. 1995. Binding of diverse peptides to MHC class I molecules inhibits target cell lysis by activated natural killer cells. Immunity 2:61.
43. Malnati, M. S., M. Peruzzi, K. C. Parker, W. E. Biddison, E. Ciccone, A. Moretta, and E. O. Long. 1995. Peptide specificity in the recognition of MHC class I by natural killer cell clones. Science 267:1016.
44. Gavioli, R., Q.-J. Zhang, and M. G. Masucci. 1996. HLA-A11-mediated protection from NK cell-mediated lysis. Role of HLA-A11-presented peptides. Hum. Immunol. 49:1.
45. Peruzzi, M., K. C. Parker, E. O. Long, and M. S. Malnati. 1996. Peptide sequence requirements for the recognition of HLA-B*2705 by specific natural killer cells. J. Immunol. 157:3350.
46. Biassoni, R., C. Cantoni, M. Falco, S. Verdiani, C. Bottino, M. Vitale, R. Conte, A. Poggi, A. Moretta, and L. Moretta. 1996. The human leukocyte antigen (HLA)-C-specific "activatory" or "inhibitory" natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions. J. Exp. Med. 183:645.
47. Lanier, L. L., J. E. Gumperz, P. Parham, I. Melero, M. López-Botet, and J. H. Phillips. 1995. The NKB1 and HP-3E4 NK cell receptors are structurally distinct glycoproteins and independently recognize polymorphic HLA-B and HLA-C molecules. J. Immunol. 154:3320.
48. Sivori, S., M. Vitale, C. Bottino, E. Marcenaro, L. Sanseverino, S. Parolini, L. Moretta, and A. Moretta. 1996. CD94 functions as a natural killer cell inhibitory receptor for different HLA class I alleles: identification of the inhibitory form of CD94 by the use of novel monoclonal antibodies. Eur. J. Immunol. 26:2487.
49. Colonna, M., G. Borsellino, M. Falco, G. B. Ferrara, and J. L. Strominger. 1993. HLA-C is the inhibitory ligand that determines dominant resistance to lysis by NK1-and NK2-specific natural killer cells. Proc. Natl. Acad. Sci. USA 90:12000.
50. Reiter, Z., D. G. Fischer, and M. Rubinstein. 1988. The protective effect of interferon against natural killing activity is not mediated via the expression of class I MHC antigens. Immunol. Lett. 17:323.
51. Leiden, J. M., B. A. Karpinski, L. Gottschalk, and J. Kornbluth. 1989. Susceptibility to natural killer cell-mediated cytolysis is independent of the level of target cell class I HLA expression. J. Immunol. 142:2140.
52. Reiter, Z., Y. Reiter, Z. Fishelson, M. Shinitzky, A. Kessler, A. Loyter, O. Nussbaum, and M. Rubinstein. 1991. Resistance to NK cell-mediated cytotoxicity (in K-562 cells) does not correlate with class I MHC antigen levels. Immunobiology 183:23.
53. Shimizu, Y., D. E. Geraghty, B. H. Koller, H. T. Orr, and R. DeMars. 1988. Transfer and expression of three cloned human non-HLA-A,B,C class I major histocompatibility complex genes in mutant lymphoblastoid cells. Proc. Natl. Acad. Sci. USA 85:227.
54. Shimizu, Y., and R. DeMars. 1989. Demonstration by class I gene transfer that reduced susceptibility of human cells to natural killer cell-mediated lysis is inversely correlated with HLA class I antigen expression. Eur. J. Immunol. 19:447.
55. Kovats, S., E. K. Main, C. Librach, M. Stubblebine, S. J. Fisher, and R. DeMars. 1990. A class I antigen, HLA-G, expression in human trophoblasts. Science 248: 220.
56. Pazmany, L., O. Mandelboim, M. Valés-Gómez, D. M. Davis, H. T. Reyburn, and J. L. Strominger. 1996. Protection from natural killer cell-mediated lysis by HLA-G expression on target cells. Science 274:792.
57. Das, B., M. O. Mondragon, S. Z. Tao, and A. J. Norin. 1997. Preferential interaction of a novel tumor surface protein (p38.5) with naive natural killer cells. J. Exp. Med. 185:1735.
58. Düchler, M., M. Offterdinger, H. Holzmüller, J. Lipp, C.-T. Chu, B. Aschauer, F. H. Bach, and E. Hofer. 1995. NKG2-C is a receptor on human natural killer cells that recognizes structures on K562 target cells. Eur. J. Immunol. 25:2923.